Rewalk Robotics Analyst Ratings
HC Wainwright & Co. Maintains Buy on Rewalk Robotics, Raises Price Target to $13
HC Wainwright & Co. : Maintaining the Rewalk Robotics (LFWD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $9.00 to $13.00.
Analysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Rewalk Robotics (LFWD) and Apellis Pharmaceuticals (APLS)
HC Wainwright & Co. : Rewalk Robotics (LFWD.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $9.00.
Rewalk Robotics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rewalk Robotics, Maintains $9 Price Target
HC Wainwright & Co. Reiterates Buy on Rewalk Robotics, Maintains $3 Price Target
Analysts Have Conflicting Sentiments on These Healthcare Companies: Irhythm Technologies (IRTC), Ventyx Biosciences (VTYX) and Rewalk Robotics (LFWD)
HC Wainwright & Co. Reiterates Buy on ReWalk Robotics, Maintains $3 Price Target
ReWalk Robotics Analyst Ratings
H.C. Wainwright Remains a Buy on Rewalk Robotics (RWLK)
HC Wainwright & Co. Reiterates Buy on ReWalk Robotics, Maintains $3 Price Target
ReWalk Robotics Analyst Ratings
ReWalk Robotics Analyst Ratings
Rewalk Robotics (RWLK) Gets a Buy From H.C. Wainwright
Analysts Are Bullish on These Technology Stocks: Tesla (TSLA), Rewalk Robotics (RWLK)
HC Wainwright & Co. Reiterates Buy on ReWalk Robotics, Maintains $3 Price Target
H.C. Wainwright Sticks to Their Buy Rating for Rewalk Robotics (RWLK)
Rewalk Robotics (RWLK) Gets a Buy From H.C. Wainwright
No Data